Another set of extrapolations - just interesting for perspective on future value:
- AMGEN's first-year revenues for their BLINCYTO drug for treating ALL was USD $77M (2015 revenue)
- AML is 3.2x the incidence of ALL, so extrapolating, first-year revenue from Bisantrene would be in the order of USD $246M
- Cinuvel (CUV) revenue for 2019 was AUD $31M, their market cap is currently AUD $1.28B
- CUV revenue to market cap multiple is 41.3x
- So 41.3x estimated first year sales for Bisantrene would imply a Market Cap of AUD $14.66B if RACE Oncology took Bisantrene through to production and sales.
Looking at Revenue growth .... it's revenue growth of BioTechs that drive high market caps when they are generating revenues.
BLINCYTO revenues grew at an average 46% per year for 5 years (this is actual growth of AMGEN's BLINCYTO revenues). Extraordinary!
More conservative view would be ramping up to peak revenues over 7years but at a slower rate. This is from one of the research notes on PAR:
- Forums
- ASX - By Stock
- RAC
- RACE Oncology Valuation - June 2020
RACE Oncology Valuation - June 2020, page-42
-
- There are more pages in this discussion • 174 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
TG1
TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
MND
Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.54 |
Change
-0.015(0.97%) |
Mkt cap ! $261.5M |
Open | High | Low | Value | Volume |
$1.55 | $1.55 | $1.50 | $111.4K | 73.35K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $1.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.56 | 1400 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 1.525 |
1 | 828 | 1.505 |
2 | 4000 | 1.490 |
1 | 38500 | 1.480 |
3 | 22244 | 1.450 |
Price($) | Vol. | No. |
---|---|---|
1.555 | 1400 | 1 |
1.640 | 1000 | 1 |
1.650 | 14314 | 2 |
1.690 | 585 | 1 |
1.745 | 12000 | 1 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
KAI
Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
MND
Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated
RAC (ASX) Chart |